| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director | Head of R&D
2 companies
Lenz Robert A. serves as a Head of R&D at NMRA and has filed Form 4s across 2 companies. Across recent SEC filings that breaks down to 0 buys and 6 sells. Those positions are worth an estimated $517K at current prices.
Historically, Lenz Robert A.'s trades have earned a strong insider score of 80/100 across 6 rated trades. Over a 12-month horizon, 83.3% of those trades were profitable, with an average 12-month return of +55.9%.
The biggest single holding is NMRA (~$517K) as Head of R&D. The recent filings there lean toward selling, a net 93,849 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Feb 18, 2025 | NMRA Neumora Therapeutics, Inc. | Head of R&D | Sell10b5-1 | 5,614 | $1.67 | $9,383.24 | -1.8% | -60.1% | +107.5% | |
| Oct 10, 2024 | NMRA Neumora Therapeutics, Inc. | Head of R&D | Sell10b5-1 | 13,823 | $15.06 | $208,110.23 | -4.2% | -84.6% | -87.7% | |
| Sep 18, 2024 | NMRA Neumora Therapeutics, Inc. | Head of R&D | Sell10b5-1 | 41,464 | $11.89 | $492,826.58 | -11.2% | -11.0% | -87.1% | |
| Sep 12, 2024 | NMRA Neumora Therapeutics, Inc. | Head of R&D | Sell10b5-1 | 32,948 | $11.43 | $376,664.83 | -8.2% | -11.1% | -86.3% |